Davis Polk advised the representatives of the several underwriters in the offering. Natera, Inc. announced its follow-on offering of 11,430,000 shares of common stock for total gross...
You must be a Standard 1 Year member to access this content.
Covington represented the underwriters on the deal. Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders,...
You must be a Standard 1 Year member to access this content.
Cooley advised Vaxcyte, while Latham & Watkins represented the underwriters on the offering. Vaxcyte, a clinical-stage vaccine innovation company, announced its underwritten public offering of common stock and...
You must be a Standard 1 Year member to access this content.
Covington represented the placement agents on the deal. Immunic, Inc. (Nasdaq: IMUX) (“Immunic” or the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of selective oral...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. Homburger advised VectivBio. VectivBio Holding AG (Nasdaq: VECT) has announced the pricing of an underwritten offering of 16,700,000...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Immatics on the offering while Covington represented underwriters. Immatics N.V. executed its $110 million SEC-registered offering of ordinary shares. The ordinary shares are...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of...
You must be a Standard 1 Year member to access this content.
Cooley represented Immunovant, while Latham & Watkins represented the underwriters in the offering. Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company committed to enabling normal lives for...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Alpine, while Latham & Watkins represented to underwriters in the offering. Alpine Immune Sciences, Inc. (Nasdaq: ALPN) has announced the pricing...
You must be a Standard 1 Year member to access this content.
Goodwin Procter represented Wayfair, while Davis Polk advised the representatives of the initial purchasers in the offering. Wayfair Inc. completed its offering of $690 million aggregate principal...
You must be a Standard 1 Year member to access this content.
Davis Polk advised SVB Securities LLC, the sole initial purchaser, in the offering. Assertio Holdings, Inc. executed the offering of $70 million aggregate principal amount of...
You must be a Standard 1 Year member to access this content.
Cooley represented Mirum Pharmaceuticals, while Latham & Watkins represented the underwriters in the offering. Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition,...
You must be a Standard 1 Year member to access this content.
